Miromatrix Medical Inc.

MIRO · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Market Cap$61,977$95,695$161,085$159,710
- Cash$5,208$52,812$4,444$3,250
+ Debt$3,552$831$7,342$1,138
Enterprise Value$60,321$43,714$163,983$157,598
Revenue$953$33$47$250
% Growth2,783.5%-28.9%-81.4%
Gross Profit$453-$467-$453$0
% Margin47.6%-1,412.1%-974.6%0%
EBITDA-$29,697-$13,828-$11,446-$9,134
% Margin-3,114.7%-41,820.4%-24,598.5%-3,653.7%
Net Income-$30,008-$14,956-$8,716-$3,070
% Margin-3,147.2%-45,230%-18,732.7%-1,228.1%
EPS Diluted-1.45-0.73-0.82-0.29
% Growth-98.6%11%-182.8%
Operating Cash Flow-$26,683-$14,809-$8,038-$8,325
Capital Expenditures-$1,063-$3,383-$123-$101
Free Cash Flow-$27,746-$18,192-$8,161-$8,426
Miromatrix Medical Inc. (MIRO) Financial Statements & Key Stats | AlphaPilot